Integer Supports Respicardia’s Commercialization in the Central Sleep Apnea Market through Two New Agreements
14 janv. 2019 16h05 HE
|
Integer Holdings Corporation
PLANO, Texas and MINNETONKA, Minn., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Integer, a leading medical device outsource (MDO) manufacturer, today announced it has entered into a new development agreement...